StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$1.89−0.05 (-2.58%)

Close on Nov 16, 2026Market cap $18.22MP/E –Yield –

Edesa Biotech ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Edesa Biotech's ebitda for the twelve months ending Jun 30, 2026 was -$14.53M. For fiscal 2025 it was -$7.79M. The highest annual figure on record is -$4.76M in fiscal 2016.

Annual ebitda

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$7.79M–
FY2024Sep 30, 2024-$6.83M–
FY2023Sep 30, 2023-$9.04M–
FY2022Sep 30, 2022-$18.25M–
FY2021Sep 30, 2021-$23.56M–
FY2020Sep 30, 2020-$6.34M–
FY2018Sep 30, 2018-$4.89M–
FY2017Sep 30, 2017-$5.05M–
FY2016Sep 30, 2016-$4.76M–
FY2014Aug 31, 2014-$5.56M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$5.49M–
Q2 FY2026CQ1 2026Mar 31, 2026-$4.27M–
Q1 FY2026CQ4 2025Dec 31, 2025-$2.32M–
Q4 FY2025CQ3 2025Sep 30, 2025-$2.44M–
Q3 FY2025CQ2 2025Jun 30, 2025-$1.88M–
Q2 FY2025CQ1 2025Mar 31, 2025-$1.61M–
Q1 FY2025CQ4 2024Dec 31, 2024-$1.86M–
Q4 FY2024CQ3 2024Sep 30, 2024-$960.19K–
Q3 FY2024CQ2 2024Jun 30, 2024-$1.88M–
Q2 FY2024CQ1 2024Mar 31, 2024-$2.18M–
Q1 FY2024CQ4 2023Dec 31, 2023-$1.81M–
Q4 FY2023CQ3 2023Sep 30, 2023-$2.32M–
Q3 FY2023CQ2 2023Jun 30, 2023-$1.98M–
Q2 FY2023CQ1 2023Mar 31, 2023-$2.38M–
Q1 FY2023CQ4 2022Dec 31, 2022-$2.35M–
Q4 FY2022CQ3 2022Sep 30, 2022-$2.81M–
Q3 FY2022CQ2 2022Jun 30, 2022-$5.77M–
Q2 FY2022CQ1 2022Mar 31, 2022-$4.55M–
Q1 FY2022CQ4 2021Dec 31, 2021-$5.13M–
Q4 FY2021CQ3 2021Sep 30, 2021-$5.46M–
Q3 FY2021CQ2 2021Jun 30, 2021-$6.04M–
Q2 FY2021CQ1 2021Mar 31, 2021-$9.48M–
Q1 FY2021CQ4 2020Dec 31, 2020-$2.58M–
Q4 FY2020CQ3 2020Sep 30, 2020-$1.98M–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.74M–
Q2 FY2020CQ1 2020Mar 31, 2020-$1.51M–
Q1 FY2020CQ4 2019Dec 31, 2019-$1.10M–
Q3 FY2019CQ2 2019Jun 30, 2019-$1.32M–
Q2 FY2019CQ1 2019Mar 31, 2019-$540.27K–
Q1 FY2019CQ4 2018Dec 31, 2018-$405.33K–
Q4 FY2018CQ3 2018Sep 30, 2018-$1.14M–
Q3 FY2018CQ2 2018Jun 30, 2018-$375.35K–
Q2 FY2018CQ1 2018Mar 31, 2018-$1.30M–
Q1 FY2018CQ4 2017Dec 31, 2017-$1.34M–
Q4 FY2017CQ3 2017Sep 30, 2017-$1.33M–
Q3 FY2017CQ2 2017Jun 30, 2017-$1.25M–
Q2 FY2017CQ1 2017Mar 31, 2017-$1.10M–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.37M–
Q4 FY2016CQ3 2016Sep 30, 2016-$1.27M–

More Edesa Biotech figures

See a number that looks wrong?